FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Epinephrine Injection, 0.1 mg/mL
Status: Currently in Shortage
»Date first posted: 04/27/2012
»Therapeutic Categories: Cardiovascular; Pulmonary/Allergy

Expand all

Amphastar Pharmaceuticals, Inc./IMS (Revised 07/24/2017)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1:10,000, 10mL Luer-Jet Prefilled Syringe (NDC 76329-3316-1) (old NDC 0548-3316-00) Amphastar will regularly release products when the manufacturing delay is resolved. Amphastar is experiencing a product shortage due to a manufacturing delay. Demand increase for the drug

Hospira, Inc. (Revised 12/01/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1:10,000; 10 mL Abboject-1 ½ “ needle (NDC 0409-4921-34) Next delivery: Early December 2017; Estimated recovery: March 2018 Shortage per Manufacturer: Manufacturing Delay

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English